Company Directory - Mural Oncology plc
Company Details - Mural Oncology plc
Mural Oncology plc
WebsiteMural Oncology plc is a clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology therapies. The company’s work includes advancing novel cancer treatments, and it recently announced the discontinuation of its final analysis of Nemvaleukin in combination with KEYTRUDA.
CCI Score
CCI Score: Mural Oncology plc
0.00
Latest Event
Take Action
So what can you do? Support Mural Oncology by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
PENDING
Mural Oncology plc is currently rated as a Pending.
Not yet scored CCI Score
The CCI rating for this company is not yet available.
Alternatives
Corporation
-38.04
San Carlos, United States
-24.65
Cambridge, USA
-42.53
Corporation
0.00
Corporation
-29.38
Corporation
19.24
Corporation
0.00
Bagsværd, Denmark
32.50
Thousand Oaks, USA
13.45
Somerset, United States
1.17
Industries
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 541715
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 621511
- Medical Laboratories